Morphine is an important drug because of its usefulness in the management of pain as well as its toxicological property of producing addiction. The drug is also important as an experimental tool for defining physiological and pathological mechanisms of pain. Numerous investigators have therefore at tempted to develop procedures for the determination of morphine (1) .
Radioimmunoassay has been introduced as a method for morphine assay (2) (3) (4) . Although the procedure is very sensitive, morphine antibody crossreacts with the major metabolite, morphine-3-glucuronide, and with other levorotatory morphinans. A fluorometric procedure has been developed for the quantititation of morphine (5) . Liquid chromatography has also been em ployed for the determination of the drug with a fluorescence detector (6) . However, both of these methods detect the drug indirectly and are insufficiently sensitive for assays in small animals, especially mice. A sensitive, specific procedure for morphine assay is thus desired. Recently, the possible application of high performance liquid chro matography combined with electrochemical detection (HPLC-ECD) was discussed in relation to morphine determination (7) . The present study assesses the application of HPLC-ECD for determining the concentration of morphine in a small amount of mouse blood.
Male ICR mice, weighing about 25 g, were injected either intraperitoneally or intra venously with 40 mg/kg of morphine (Merck, Rahway, NJ, USA). The tail vein was incised, and 10 Id of blood was collected at various times after injection from the same animal using a micropipette. The blood was trans ferred to a tube containing internal standard (3,4-dihydroxyphenylpropionic acid) and 90 ,al of 3% trichloroacetic acid. After being vortexed briefly, the tube was centrifuged at 15,000 rpm for 20 min in a refrigerated centrifuge (Sorvall RC-5, Du Pont, Newtown, CT, USA) at 4°C. The supernatant (20 ul) was injected onto an Ultraspliere-ODS column (average particle size, 5 um; 25 cmx 4.6 mm; Altex Scientific, Berkeley, CA, USA) through a six port injector (Rheodyne, Berkeley, CA, USA). An L-2000 chromato graphic system (Yanagimoto, Kyoto, Japan) was employed with an electrochemical detector (VMD-101, Yanagimoto chromatography was performed at a flow rate of 1.0 ml/min using a mobile phase, 0.075 M sodium citrate/citric acid buffer (pH 3.75) containing 2.5% tetrahydrofuran, 10% methanol, and 6% acetic acid. The quanti titation was accomplished by comparison of the ratio of the peak heights of morphine and internal standard. In electrochemical detection, the electrode responses vary with the applied voltage (8) .
Morphine initiated the response current at an applied voltage of +425 mV vs. the reference electrode. The current increased steadily up to an applied voltage of +800 mV and then reached a plateau. The current is probably due to the one electron oxidation of the phenolic OH group at the 3-position of the structure because codeine, which has no OH in this position, did not respond even with +800 mV. In the present study, a value of +725 mV vs. the reference electrode was chosen for the assay because of the low background noise and electrode specificity.
The electrochemical responses gave linear quantitative results over a wide range of morphine concentrations from 500 pg to 1 itg. The recovery and reproducibility were also studied by adding known quantities of morphine to blank samples of whole blood and analyzing the samples according to the procedure described above. Little loss of morphine was determined by the present procedure for sample preparations. As regards to the reproducibility, the coefficient of variation was estimated to be 4.4%.
Previous chromatographic determinations of morphine have been limited by the fact that the substance adsorbed non-linearly on the column, and the peak showed marked tailing. The present chromatograms, on the other hand, indicated good symmetry for the substance (Fig. 1) . The column, which had been packed with Ultrasphere-ODS reverse phase resin, showed a theoretical number of over 7,000 for morphine. Furthermore, no biological substances occupied the same retention time as morphine and interfered with the quantititation of the drug. In addition to morphine, tyrosine and tryptophan were chromatographically and electrochemically identified and detected in the same sample (no data are represented).
5-Hydroxytrypta mine (5-HT) was also identified on the shoulder slope of the drug. However, the concentration of 5-HT was so low compared to that of the drug that there was no adverse influence on the determination of the mor phine ( Fig. 1) . One assay was completed within about 10 min. The time course of the morphine concen tration in the blood was determined after intraperitoneal and intravenous injections ( Fig. 2) . A concentration of 19.1 ±3.7 /tg/mI was detected 2 min after intravenous injection of the drug. The biological half life of morphine following intravenous injection was estimated to be 42±2 min in mouse whole blood. This value agreed with a previous report in which the radioimmunoassay was used for morphine determination (2) . The maximum concentration for the intraperitoneal route was recorded 30 min after the injection, with a concentration of 4.3±0.8 /cg/ml. In the case of the intraperitoneal route, the biological half life (elimination phase) was estimated to be 49±6 min. The difference between biological half lives for the intravenous and intraperitoneal route is considered to be due to the absorption of the drug.
Wallace et al. demonstrated a HPLC-ECD procedure for determining morphine concen trations in the blood (7) . The procedure, however, required a 2 ml sample and a complex extraction process for the deter mination. The volume is impossible to be taken from small animals, especially mice.
The proposed method used only 10 /l of the blood for the determination of morphine with a simple pretreatment (deproteinization), and it provided a substantial lowering of the detection limit compared to a previous chromatographic technique (6) . The detec tability of the present method is comparable to that of radioimmunoassay (2-4) and the radiotracer technique (10) .
